Abstract
Microglia are the resident macrophages in the brain. Traditionally, two forms of microglia have been described: one considered as a resting/surveillant state in which cells have a highly branched morphology, and another considered as an activated state in which they acquire a de-ramified or amoeboid form. However, many studies describe intermediate microglial morphologies which emerge during pathological processes. Since microglial form and function are closely related, it is of interest to correlate microglial morphology with the extent of its activation. To address this issue, we used a rat model of neuroinflammation consisting in a single injection of the enzyme neuraminidase (NA) within the lateral ventricle. Sections from NA-injected animals were co-immunolabeled with the microglial marker IBA1 and the cytokine IL-1β, which highlight features of the cell’s shape and inflammatory activation, respectively. Activated (IL-1β positive) microglial cells were sampled from the dorsal hypothalamus nearby the third ventricle. Images of single microglial cells were processed in two different ways to obtain (1) an accurate measure of the level of expression of IL-1β (indicating the degree of activation), and (2) a set of 15 morphological parameters to quantitatively and objectively describe the cell’s shape. A simple regression analysis revealed a dependence of most of the morphometric parameters on IL-1β expression, demonstrating that the morphology of microglial cells changes progressively with the degree of activation. Moreover, a hierarchical cluster analysis pointed out four different morphotypes of activated microglia, which are characterized not only by morphological parameters values, but also by specific IL-1β expression levels. Thus, these results demonstrate in an objective manner that the activation of microglial cells is a gradual process, and correlates with their morphological change. Even so, it is still possible to categorize activated cells according to their morphometric parameters, each category presenting a different activation degree. The physiological relevance of those activated morphotypes is an issue worth to be assessed in the future.
Highlights
Microglial cells are the resident macrophages in the central nervous system
The ICV administration of NA results in the activation of microglial cells located nearby the ventricular walls, activation that is evidenced by IL-1β expression
Double immunofluorescence showed a broad co-localization of IL-1β in IBA1 positive cells located in periventricular areas, of the hypothalamus (Figure 3)
Summary
Microglial cells are the resident macrophages in the central nervous system They were considered to be “resting” or “quiescent” in normal or healthy conditions, eventually acquiring an activated phenotype in pathological situations (Davis et al, 1994). Under various stimulus (e.g., infection, trauma or stroke) microglia may acquire different activated phenotypes to engage immunological or repair functions (Ransohoff and Perry, 2009). Those activated phenotypes have been defined as classical activation (M1), alternative activation (M2a), type II alternative activation (M2b), and acquired deactivation (M2c). M1 is considered a pro-inflammatory phenotype, while M2 subtypes are considered anti-inflammatory states This classification is highly controversial, and many authors do not agree with it. Microglial cells can play a confusing toxic or protective role in particular neurological pathologies (Biber and Block, 2014), which represents a crucial issue to unravel
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.